NPAS3
Basic information
Region (hg38): 14:32934396-33820863
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPAS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 43 | 47 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 44 | 10 | 7 |
Variants in NPAS3
This is a list of pathogenic ClinVar variants found in the NPAS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-33215174-G-A | Likely benign (Oct 10, 2018) | |||
14-33215287-A-C | Likely benign (Aug 01, 2023) | |||
14-33215335-T-C | Benign (Nov 16, 2018) | |||
14-33215391-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
14-33676202-G-A | Benign (Sep 24, 2018) | |||
14-33676268-A-C | not specified | Uncertain significance (Apr 04, 2023) | ||
14-33676298-C-A | not specified | Uncertain significance (Jan 23, 2023) | ||
14-33676349-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
14-33774351-A-G | Likely benign (Aug 09, 2018) | |||
14-33774364-C-G | not specified | Uncertain significance (May 08, 2023) | ||
14-33774373-T-G | not specified | Uncertain significance (Dec 21, 2023) | ||
14-33774418-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
14-33774490-C-T | Uncertain significance (Nov 01, 2022) | |||
14-33774509-A-G | not specified | Uncertain significance (Apr 04, 2023) | ||
14-33778542-G-C | not specified | Uncertain significance (Nov 17, 2022) | ||
14-33797523-C-T | Benign (Dec 31, 2019) | |||
14-33797565-C-A | not specified | Uncertain significance (Feb 27, 2024) | ||
14-33799745-A-G | not specified | Uncertain significance (Apr 12, 2022) | ||
14-33799775-T-A | not specified | Uncertain significance (Jun 30, 2022) | ||
14-33799786-C-T | Benign (Jul 31, 2018) | |||
14-33799807-G-C | Likely benign (Nov 01, 2022) | |||
14-33799812-A-C | not specified | Uncertain significance (Mar 01, 2023) | ||
14-33799838-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
14-33799877-G-A | Uncertain significance (Feb 12, 2022) | |||
14-33799946-T-C | not specified | Uncertain significance (Dec 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPAS3 | protein_coding | protein_coding | ENST00000356141 | 12 | 869244 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000263 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.14 | 364 | 576 | 0.632 | 0.0000364 | 6016 |
Missense in Polyphen | 107 | 176.12 | 0.60755 | 1802 | ||
Synonymous | 0.445 | 251 | 260 | 0.965 | 0.0000199 | 1873 |
Loss of Function | 5.16 | 3 | 36.8 | 0.0815 | 0.00000204 | 405 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a broad role in neurogenesis. May control regulatory pathways relevant to schizophrenia and to psychotic illness (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.347
- rvis_EVS
- -1.35
- rvis_percentile_EVS
- 4.6
Haploinsufficiency Scores
- pHI
- 0.301
- hipred
- Y
- hipred_score
- 0.752
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npas3
- Phenotype
- respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;cytosol
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein heterodimerization activity